A study for a 46 year old woman who takes Medroxyprogesterone Acetate, Synthroid - from FDA reports


Summary

416 females aged 46 (±5) who take the same drugs are studied. This is a personalized study for a 46 year old female patient who has Menorrhagia, Underactive Thyroid. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 16, 2017

416 females aged 46 (±5) who take Medroxyprogesterone Acetate, Synthroid are studied.


Number of reports submitted per year:

Medroxyprogesterone Acetate, Synthroid for a 46-year old woman.

Information of the patient in this study:

  • Age: 46
  • Gender: female
  • Conditions: Menorrhagia, Underactive Thyroid
  • Drugs taken:
    • Medroxyprogesterone Acetate (medroxyprogesterone acetate)
    • Synthroid (levothyroxine sodium)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Petechiae: 0 (0% of females aged 46 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • blood count abnormal
  • dizziness
  • gait disturbance
  • nausea
  • breathing difficulty
  • haematochezia
  • haematuria
  • breast cancer
  • weight increased
  • vaginal bleeding between periods
1 - 6 months:
  • gallstones
  • breast cancer female
  • pulmonary embolism
  • deep venous thrombosis
  • adenomyosis
  • kidney stones
  • endometrial cancer
  • cholecystitis acute
  • abdominal pain
  • pelvic pain
6 - 12 months:
  • breast cancer
  • vaginal haemorrhage
  • skin infection
  • pneumonia
  • bell's palsy
  • upper respiratory tract infection
  • cholecystitis acute
  • tooth extraction
  • pharyngitis
  • carbuncle
1 - 2 years:
  • breast cancer
  • weight decreased
  • breast cancer female
  • chest pain
  • breathing difficulty
  • hypersensitivity
  • dehydration
  • high blood pressure
  • diabetes
  • blood sodium decreased
2 - 5 years:
  • breast cancer female
  • breast cancer
  • fatigue
  • stress and anxiety
  • joint pain
  • pain
  • injury
  • depression
  • flank pain
  • stroke
5 - 10 years:
  • breast cancer female
  • pain in extremity
  • vulvovaginal dryness
  • hot flush
  • breast lump
  • fibrocystic breast disease
  • breathing difficulty
  • emotional distress
  • exostosis
  • breast cyst
10+ years:
  • breast cancer female
  • nausea
  • post procedural infection
  • speech impairment (adult)
  • meningioma
  • multiple sclerosis
  • meningioma benign
  • mental status changes
  • breast cancer
  • stress and anxiety
not specified:
  • breast cancer female
  • breast cancer
  • nausea
  • chest pain
  • joint pain
  • stress and anxiety
  • breathing difficulty
  • pain
  • fatigue
  • drug ineffective

Top conditions involved for these people *:

  • High Blood Pressure (38 people, 9.13%)
  • Depression (36 people, 8.65%)
  • High Blood Cholesterol (22 people, 5.29%)
  • Pain (21 people, 5.05%)
  • Menopause (21 people, 5.05%)

Top co-used drugs for these people *:

  • Premarin (157 people, 37.74%)
  • Prempro (54 people, 12.98%)
  • Zoloft (47 people, 11.30%)
  • Neurontin (32 people, 7.69%)
  • Estrace (28 people, 6.73%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

  • Petechiae (a small red or purple spot caused by bleeding into the skin) has been reported by people with high blood pressure, rheumatoid arthritis, idiopathic thrombocytopenic purpura, atrial fibrillation/flutter, depression (latest reports from 8,777 Petechiae patients).

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Menorrhagia, Medroxyprogesterone acetate, Underactive thyroid, Synthroid, Petechiae

You may be interested in these reviews

More reviews for: Menorrhagia, Medroxyprogesterone acetate, Underactive thyroid, Synthroid, Petechiae